Eleftherios Michailidis
Emory University(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Hepatitis B Virus Studies, HIV/AIDS drug development and treatment, HIV Research and Treatment, Hepatitis C virus research
Most-Cited Works
- → Autoantibodies against type I IFNs in patients with life-threatening COVID-19(2020)2,815 cited
- → Inborn errors of type I IFN immunity in patients with life-threatening COVID-19(2020)2,377 cited
- → Convergent antibody responses to SARS-CoV-2 in convalescent individuals(2020)2,126 cited
- → Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants(2020)1,457 cited
- → Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses(2020)628 cited
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → Enhanced SARS-CoV-2 neutralization by dimeric IgA(2020)520 cited
- → Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks(2020)432 cited
- → CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus(2015)297 cited
- → LY6E impairs coronavirus fusion and confers immune control of viral disease(2020)234 cited